1. Home
  2. LUCD vs SVII Comparison

LUCD vs SVII Comparison

Compare LUCD & SVII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LUCD
  • SVII
  • Stock Information
  • Founded
  • LUCD 2018
  • SVII 2021
  • Country
  • LUCD United States
  • SVII United States
  • Employees
  • LUCD N/A
  • SVII N/A
  • Industry
  • LUCD Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • SVII Blank Checks
  • Sector
  • LUCD Health Care
  • SVII Finance
  • Exchange
  • LUCD Nasdaq
  • SVII Nasdaq
  • Market Cap
  • LUCD 112.5M
  • SVII 117.1M
  • IPO Year
  • LUCD 2021
  • SVII 2022
  • Fundamental
  • Price
  • LUCD $1.11
  • SVII $11.85
  • Analyst Decision
  • LUCD Strong Buy
  • SVII
  • Analyst Count
  • LUCD 4
  • SVII 0
  • Target Price
  • LUCD $3.94
  • SVII N/A
  • AVG Volume (30 Days)
  • LUCD 1.5M
  • SVII 2.4K
  • Earning Date
  • LUCD 08-11-2025
  • SVII 01-01-0001
  • Dividend Yield
  • LUCD N/A
  • SVII N/A
  • EPS Growth
  • LUCD N/A
  • SVII N/A
  • EPS
  • LUCD N/A
  • SVII 0.25
  • Revenue
  • LUCD $4,173,000.00
  • SVII N/A
  • Revenue This Year
  • LUCD $49.70
  • SVII N/A
  • Revenue Next Year
  • LUCD $198.20
  • SVII N/A
  • P/E Ratio
  • LUCD N/A
  • SVII $47.78
  • Revenue Growth
  • LUCD 39.89
  • SVII N/A
  • 52 Week Low
  • LUCD $0.72
  • SVII $11.06
  • 52 Week High
  • LUCD $1.80
  • SVII $11.90
  • Technical
  • Relative Strength Index (RSI)
  • LUCD 44.54
  • SVII 58.66
  • Support Level
  • LUCD $1.08
  • SVII $11.77
  • Resistance Level
  • LUCD $1.14
  • SVII $11.78
  • Average True Range (ATR)
  • LUCD 0.07
  • SVII 0.05
  • MACD
  • LUCD 0.00
  • SVII 0.00
  • Stochastic Oscillator
  • LUCD 41.03
  • SVII 90.00

About LUCD Lucid Diagnostics Inc.

Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.

About SVII Spring Valley Acquisition Corp. II

Spring Valley Acquisition Corp II is a blank check company.

Share on Social Networks: